Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma

References

• Alizadeh AA, Eisen MB, Davis RE, et al Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
   PubMed Web of Science ®Google Scholar
• Staudt LM, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol 2005;87:163–208.
   PubMed Web of Science ®Google Scholar
• Monti S, Savage KJ, Kutok JL, et al Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 2005;105:1851–1861.
   PubMed Web of Science ®Google Scholar
• Abramson JS, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood 2005;106:1164–1174.
   PubMed Web of Science ®Google Scholar
• Uddin S, Hussain AR, Siraj AK, et al Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 2006;108:4178–4186.
   PubMed Web of Science ®Google Scholar
• Saito M, Novak U, Piovan E, et al BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2009;106:11294–11299.
   PubMed Web of Science ®Google Scholar
• Bai M, Skyrlas A, Agnantis NJ, et al Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protein bcl-xl. Mod Pathol 2004;17:847–856.
   PubMed Web of Science ®Google Scholar
• Parekh S, Privé G, Melnick A. Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas. Leuk Lymphoma 2008;49:874–882.
   PubMed Web of Science ®Google Scholar
• Deng J, Carlson N, Takeyama K, Dal Cin P, Shipp M, Letai A. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 2007;12:171–185.
   PubMed Web of Science ®Google Scholar
• Wang Z, Malone MH, He H, McColl KS, Distelhorst CW. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 2003;278:23861–23867.
   PubMed Web of Science ®Google Scholar
• Abrams MT, Robertson NM, Yoon K, Wickstrom E. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J Biol Chem 2004;279:55809–55817.
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009;324:1029–1033.
   PubMed Web of Science ®Google Scholar
• Shaffer AL, Rosenwald A, Hurt EM, et al Signatures of the immune response. Immunity 2001;15:375–385.
   PubMed Web of Science ®Google Scholar
• Faber AC, Dufort FJ, Blair D, Wagner D, Roberts MF, Chiles TC. Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochem Pharmacol 2006;72:1246–1256.
   PubMed Web of Science ®Google Scholar
• Lam LT, Wright G, Davis RE, et al Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008;111:3701–3713.
   PubMed Web of Science ®Google Scholar
• Screaton RA, Conkright MD, Katoh Y, et al The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004;119:61–74.
   PubMed Web of Science ®Google Scholar
• Dentin R, Liu Y, Koo SH, et al Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 2007;449:366–369.
   PubMed Web of Science ®Google Scholar
• Zhang L, Insel PA. The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 2004;279:20858–20865.
   Google Scholar
• Koo SH, Flechner L, Qi L, et al The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005;437:1109–1111.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Espinosa R 3rd, Thirman MJ, et al Variability of 11q23 rearrangements in hematopoietic cell lines identified with fluorescence in situ hybridization. Blood 1993;81:3027–3033.
   PubMed Web of Science ®Google Scholar
• Karnan S, Tagawa H, Suzuki R, et al Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 2004;39:77–81.
   PubMed Web of Science ®Google Scholar
• Tagawa H, Tsuzuki S, Suzuki R, et al Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res 2004;64:5948–5955.
   PubMed Web of Science ®Google Scholar
• Drexler HG. Guide to leukemia-lymphoma cell lines. Braunschweig: DSMZ; 2005 [eBook on CD].
   Google Scholar
• MacLeod RA, Kaufmann M, Drexler HG. Cytogenetic harvesting of commonly used tumor cell lines. Nat Protoc 2007;2:372–382.
   PubMed Web of Science ®Google Scholar
• Nagel S, Meyer C, Quentmeier H, Kaufmann M, Drexler HG, MacLeod RA. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines. Leukemia 2008;22:600–607.
   PubMed Web of Science ®Google Scholar
• Nagel S, Burek C, Venturini L, et al Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. Blood 2007;109:3015–3023.
   PubMed Web of Science ®Google Scholar
• Nagel S, Kaufmann M, Drexler HG, MacLeod RA. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res 2003;63:5329–5334.
   PubMed Web of Science ®Google Scholar
• Nagel S, Scherr M, Quentmeier H, et al HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3. Leukemia 2005;19:841–846.
   PubMed Web of Science ®Google Scholar
• Brown PJ, Ashe SL, Leich E, et al Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood 2008;111:2816–2824.
   PubMed Web of Science ®Google Scholar
• Wilson BE, Mochon E, Boxer LM. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol Cell Biol 1996;16:5546–5556.
   PubMed Web of Science ®Google Scholar
• Hummel M, Bentink S, Berger H, et al A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006;354:2419–2430.
   PubMed Web of Science ®Google Scholar
• Lenz G, Wright GW, Emre NC, et al Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 2008;105:13520–13525.
   PubMed Web of Science ®Google Scholar
• Dave SS, Wright G, Tan B, et al Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 2004;351:2159–2169.
   PubMed Web of Science ®Google Scholar
• Dyer MJ, Fischer P, Nacheva E, Labastide W, Karpas A. A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t (14;18) and t(4;11) chromosomal translocations. Blood 1990;75:709–714.
   PubMed Web of Science ®Google Scholar